TOP TIERMARKET NEWSWIRE

News & sentiment

NUVALENT INC A (NUVL) — News & AI sentiment

NUVALENT INC A (NUVL) news roundup. 1 story in the past week, 4 over 30 days. Average 30-day sentiment is 60.8/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 10 sales totalling $16.3M — net selling of $16.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

1

avg sentiment 58/100

30d stories

4

avg sentiment 60.8/100

Insider net (90d)

$16.3M

0 buys · 10 sells

Congress (90d)

0

0 buys · 0 sells

Latest stories on NUVL

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline — Update

Morningstar58 · neutralm&a

2d ago

GSK: Buy The Discount Before The Catalysts Close It

Seeking Alpha63 · neutralanalyst

Jul 21

Are NUVL, ROKU, PAYO, HUN Obtaining Fair Deals for their Shareholders?

PR Newswire55 · neutralgeneral

Jul 2

GSK plc (GSK) Launches Tender Offer to Acquire Nuvalent Inc. for $124 Per Share

Yahoo Top67 · bullishm&a

Jun 30

GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent

TipRanks67 · bullishm&a

Jun 24

Nuvalent Shareholders Endorse Board, Pay, and Auditor

TipRanks50 · neutralgeneral

Jun 18

Nuvalent, Inc. (NUVL) files 8-K

SEC 8-K50 · neutralgeneral

Jun 18

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SUNE, NUVL, CCRN, and BGMS

PR Newswire50 · neutralm&a

Jun 17

Key deals this week: GSK, Incyte, Ingredion, OpenAI, and more

Seeking Alpha50 · neutralm&a

Jun 13

Are AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?

PR Newswire50 · neutralgeneral

Jun 12

Nuvalent: 'Hold' On GlaxoSmithKline Acquisition For Selective Tyrosine Kinase Inhibitors

Seeking Alpha48 · neutralm&a

Jun 11

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

Yahoo Finance73 · bullishm&a

Jun 11

Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

MarketBeat73 · bullishm&a

Jun 11

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Reuters73 · bullishm&a

Jun 11

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Yahoo Top73 · bullishm&a

Jun 11

Deerfield Management Announces Portfolio Company Nuvalent, Inc. to be Acquired by GSK

PR Newswire78 · bullishm&a

Jun 10

Nuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVL

Morningstar46 · neutralgeneral

Jun 10

GSK's Nuvalent deal tackles HIV cliff to win cautious backing from analysts

Yahoo Top58 · neutralm&a

Jun 10

Nuvalent Stock Hits All-Time High Following GSK's Buyout Offer

Barchart78 · bullishm&a

Jun 9

GSK plc (GSK) Nuvalent, Inc. - M&A Call - Slideshow

Seeking Alpha50 · neutralm&a

Jun 9

Dow Jones Top Company Headlines at 1 PM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | J.M. ...

Morningstar63 · neutralm&a

Jun 9

Health Care Roundup: Market Talk

WSJ Markets63 · neutralm&a

Jun 9

JM Smucker Moves on Profit Beat; Vail Resorts Down on Full Year Guidance Cut | Stock Movers

Bloomberg56 · neutralearnings

Jun 9

GSK’s $10.6 Billion Nuvalent Acquisition Highlights Wall Street’s Bet on Precision Oncology Innovation

MarketChameleon76 · bullishm&a

Jun 9

Nuvalent Catapults To Record High On GSK's $10.6 Billion All-Cash Bid

Investors.com92 · bullishm&a

Jun 9

Open NUVL in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →